Rang	Name	Position
1	Dr. Jay R. Luly Ph.D.	President, CEO & Director
2	Dr. Yat Sun Or Ph.D.	Chief Scientific Officer
3	Dr. Scott T. Rottinghaus M.D.	Chief Medical Officer
4	Mr. Harry R. Trout III	VP of Finance & Interim Principal Financial Officer
5	Ms. Kathleen S. Capps CPA	Executive Director of Accounting, Controller & Interim Principal Accounting Officer
6	Ms. Jennifer Viera	Executive Director of Investor Relations & Corporate Communications
7	Mr. Matthew P. Kowalsky J.D.	Chief Legal Officer & Corporate Secretary
8	Mr. Nathaniel S. Gardiner J.D.	Consultant
9	Ms. Tara Lynn Kieffer Ph.D.	Chief Product Strategy Officer
10	Mr. Brendan Luu	Chief Business Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	HHG PLC	12,99%	49,04 Mio. USD
2	BlackRock Inc	10,66%	40,23 Mio. USD
3	Farallon Capital Management, L.L.C.	9,86%	37,22 Mio. USD
4	Krensavage Asset Management, LLC	9,84%	37,15 Mio. USD
5	Deep Track Capital, LP	4,96%	18,72 Mio. USD
6	Vanguard Capital Management, LLC	4,04%	15,27 Mio. USD
7	Spruce Street Capital LP	3,74%	14,11 Mio. USD
8	Vanguard Portfolio Management, LLC	3,26%	12,30 Mio. USD
9	Acadian Asset Management LLC	3,02%	11,41 Mio. USD
10	Geode Capital Management, LLC	2,49%	9,40 Mio. USD
11	Renaissance Technologies Corp	2,28%	8,62 Mio. USD
12	Millennium Management LLC	2,21%	8,35 Mio. USD
13	State Street Corp	1,93%	7,29 Mio. USD
14	Hillsdale Investment Management Inc.	1,61%	6,07 Mio. USD
15	AQR Capital Management LLC	1,08%	4,06 Mio. USD
16	Morgan Stanley - Brokerage Accounts	1,06%	4,01 Mio. USD
17	Charles Schwab Investment Management Inc	1,01%	3,82 Mio. USD
18	Dimensional Fund Advisors, Inc.	0,97%	3,66 Mio. USD
19	The Goldman Sachs Group Inc	0,91%	3,44 Mio. USD
20	Northern Trust Corp	0,83%	3,12 Mio. USD